References
- Sun Y, Li M, Chen L, et al. Prevalence and molecular characterization of carbapenemase-producing gram-negative bacteria from a university hospital in China. Infect Dis (Lond). 2016;48:138–146.
- Markovska R, Stoeva T, Schneider I, et al. Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniae in Bulgaria. APMIS. 2015;123:887–894.
- Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–4558.
- Clermont O, Dhanji H, Upton M, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother. 2009;64:274–277.
- Carattoli A, Bertini A, Villa L, et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–228.
- Navon-Venezia S, Chmelnitsky I, Leavitt A, et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098–3101.
- Naas T, Cuzon G, Gaillot O, et al. When carbapenem-hydrolyzing beta-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob Agents Chemother. 2011;55:4933–4934.
- Can F, Azap OK, Seref C, et al. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis. 2015;60:523–527.
- Cai JC, Zhang R, Hu YY, et al. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother. 2014;58:1146–1152.
- Piazza A, Caltagirone M, Bitar I, et al. Emergence of Escherichia coli sequence type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a long-term care and rehabilitation facility (LTCRF) in Northern Italy. Adv Exp Med Biol. 2016;901:77–89.